The diabetes testing product maker’s $86.8m Arkray 4U unit will seek out strategic entrepreneurs for its parent in areas such as digital medical equipment and functional food.

Japan-headquartered healthcare device producer Arkray has announced a ¥10bn ($86.8m) Singapore-based corporate venture capital initiative launched in a bid to back early-stage medical technology developers. Formed in November 2021, Arkray 4U will invest directly from its parent firm’s balance sheet as opposed to a dedicated fund, Arkray 4U senior investment associate Wei Cong Seah told…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.